期刊文献+

肾移植术后配伍他克莫司时血霉酚酸浓度测定的有限检样法研究 被引量:16

Evaluation of mycophenolic acid exposure by limited sampling strategy in Chinese adult renal transplant recipients receiving mycophenolate mofeil and tacrolimus
原文传递
导出
摘要 目的 研究成人肾移植术后霉酚酸的药代动力学特点,建立配伍他克莫司的血霉酚酸浓度曲线下面积的有限检样方法.方法 42例成人肾移植受者,采用吗替麦考酚酯(MMF)联合他克莫司、泼尼松的三联免疫抑制方案.血霉酚酸浓度通过高效液相色谱法测定,采血点为服药前(C0)及服药后0.5、1、1.5、2、3、4、6、9和12h,用梯形面积法计算浓度曲线下面积,采用多元线性回归分析,确定相关采血点,确定有限取样方案.结果 通过多元线性回归分析得出3点估算MPA-AUC=7.297+2.819C1.5 h+3.297C4h+4.269C9 h[相关系数(r2)=0.878],4点估算的MPA- AUC=2.519+0.549C0.5 h+1.900C1.5 h+3.931C4h+4.037C9 h(r2=0.928).采用Bland & Altman分析法评估,3点法和4点法均未超出置信限范围,二者与全点AUG0-12h有较好的一致性.3点评估AUC与全点AUG0-12h差值为(11.7±8.32)mg·h·L-1,二者差值的95%置信区间为9.18~14.37 mg·h·L-1 (P<0.01);4点评估AUC与全点AUG0-12h差值为(1.65±7.98)mg·h·L-1,二者差值的95%置信区间为-0.84~4.13 mg·h·L-1 (P<0.01).结论 该有限检样方案适用于监测成人肾移植受者配伍他克莫司用药时血霉酚酸浓度的曲线下面积. Objective To investigate the pharmacokinetics of mycophenolic acid (MPA) in Chinese adult renal allograft recipients,and to generate the validated model equations for estimation of the MPA area under the plasma concentration-time curve from 0 to 12 h (AUC0-12h) with a limitedsampling strategy.Methods The pharmacokinetics in 42 Chinese renal allograft recipients treated with mycophenolate mofetil in combination with tacrolimus and corticosteroids were determined. MPA concentration was assayed by high-performance liquid chromatography (HPLC) at pre-dose (G0) and at 0.5(G0.5h),1 (C1h),1.5 (C1.5h),2 (C2h),3(C3h),4 (C4h),6 (C6h),9 (C9h) and 12 (C12h) h,respectively.The modd equations were generated by multiple stepwise regression analysis for estimation of the MPA-AUC by a limited sampling strategy.Results The prediction formulas were as follows:MPA-AUC1.5 h-4h-9 h =7.297 + 2.819C1.5 h + 3.297C4 h + 4.269C9 h ( r2 =0.878) ; and MPA-AUG0.5 h-1.5 h-4 h-9 h =2.519 + 0.549G0.5 h + 1.900 C1.5 h + 3.931 C4 h + 4.037C9 h (r2 =0.928).We plotted the average of estimated AUC and full MPA-AUC0-12 h.The Bland 8 Altman analysis indicated good agreement to within 1.96SD.Mean difference of the prediction formula using the three time points of C1.5 h-C4 h-C9 h was (11.7 ± 8.32) mg·h·L-1 and 95% confidence interval (CI) was (9.18~14.37) mg·h·L-1,p〈0.01 ; mean difference of the prediction formula using the four time points of G0.5 h-C1.5 h C4 h-C9 h was (1.65-±7.98) mg·h·L-1,and 95% CI (-0.84~4.13) mg·h·L-1,P〈0.01.Conclusion This limited sampling strategy provides an effective approach for estimation of full MPA AUC0-12 h in Chinese adult renal allograft recipients treated with mycophenolate mofetil in combination with tacrolimus in the stable post transplant period.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2012年第2期101-104,共4页 Chinese Journal of Organ Transplantation
关键词 肾移植 霉酚酸 药代动力学 Kidney transplantation Mycophenolic acid Pharmacokinetics
  • 相关文献

参考文献18

  • 1Wang CX, Meng FH, Chen LZ, et al. Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients. Transplant Proc,2007,39 (5):1392-1395.
  • 2van Gelder T,Silva HT,de Fijter H,et al. How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.Ther Drug Monit,2011,33(2):155-164.
  • 3de Jonge H,Naesens M,Kuypers DR.New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid:possible consequences for therapeutic drug monitoring in solid organ transplantation.Ther Drug Monit,2009,31 (4):416-435.
  • 4van Gelder T,Klupp J,Barten MJ,et al.Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of ruycophenolic acid.Ther Drug Monit,2001,23 (2):119-128.
  • 5Zhou PJ, Xu D, Yu ZC, et al. Pharmacokinetics of mycophenolic acid and estimation of exposure using multiple linear regression equations in Chinese renal allograft recipients.Clin Pharmacokinet,2007,46(5):389-401.
  • 6Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement.Lancet,1986,1 (8476):307-310.
  • 7Allison AC, Eugui EM. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.Transplantation,2005,80(2 Suppl):S181-S190.
  • 8Scott LJ,Mckeage K,Keam SJ,et al.Tacrolimus:a further update of its use in the management of organ transplantation.Drugs,2003,63(12):1247-1297.
  • 9Shaw LM, Korecka M, Venkataramanan R, et al.Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant,2003,3(5):534-542.
  • 10van Gelder T,Le Meur Y,Shaw LM,et al.Therapeutic drug monitoring of mycophenolate mofetil in transplantation.Ther Drug Monit,2006,28(2):145-154.

同被引文献113

引证文献16

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部